These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 16047643

  • 21. ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritis.
    Woo KT, Lau YK, Wong KS, Chiang GS.
    Kidney Int; 2000 Dec; 58(6):2485-91. PubMed ID: 11115082
    [Abstract] [Full Text] [Related]

  • 22. Additive antiproteinuric effect of combination therapy with ACE inhibitor and angiotensin II receptor antagonist: differential short-term response between IgA nephropathy and diabetic nephropathy.
    Kim MJ, Song JH, Suh JH, Lee SW, Kim GA.
    Yonsei Med J; 2003 Jun 30; 44(3):463-72. PubMed ID: 12833584
    [Abstract] [Full Text] [Related]

  • 23. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for IgA nephropathy.
    Dillon JJ.
    Semin Nephrol; 2004 May 30; 24(3):218-24. PubMed ID: 15156527
    [Abstract] [Full Text] [Related]

  • 24. Dual renin-angiotensin system blockade for nephroprotection: still under scrutiny.
    Gentile G, Remuzzi G, Ruggenenti P.
    Nephron; 2015 May 30; 129(1):39-41. PubMed ID: 25531311
    [Abstract] [Full Text] [Related]

  • 25. Antiproteinuric response to dual blockade of the renin-angiotensin system in primary glomerulonephritis: meta-analysis and metaregression.
    Catapano F, Chiodini P, De Nicola L, Minutolo R, Zamboli P, Gallo C, Conte G.
    Am J Kidney Dis; 2008 Sep 30; 52(3):475-85. PubMed ID: 18468748
    [Abstract] [Full Text] [Related]

  • 26. ACEI/ARB therapy for IgA nephropathy: a meta analysis of randomised controlled trials.
    Cheng J, Zhang W, Zhang XH, He Q, Tao XJ, Chen JH.
    Int J Clin Pract; 2009 Jun 30; 63(6):880-8. PubMed ID: 19490198
    [Abstract] [Full Text] [Related]

  • 27. Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: a systematic review and meta-analysis of randomized controlled trials.
    Lakhdar R, Al-Mallah MH, Lanfear DE.
    J Card Fail; 2008 Apr 30; 14(3):181-8. PubMed ID: 18381180
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Prospective trial of combined therapy with heparin/warfarin and renin-angiotensin system inhibitors in progressive IgA nephropathy.
    Ishii T, Kawamura T, Tsuboi N, Ogura M, Utsunomiya Y, Hosoya T.
    Contrib Nephrol; 2007 Apr 30; 157():114-9. PubMed ID: 17495447
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Clinical course of patients with IgA nephropathy between combined treatment of immunosuppressive agents and ACE inhibitor and ACE inhibitor alone.
    Hwang YC, Lee TW, Kim MJ, Yang MH, Ihm CG.
    Korean J Intern Med; 2001 Jun 30; 16(2):105-9. PubMed ID: 11590896
    [Abstract] [Full Text] [Related]

  • 34. Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy.
    Russo D, Pisani A, Balletta MM, De Nicola L, Savino FA, Andreucci M, Minutolo R.
    Am J Kidney Dis; 1999 May 30; 33(5):851-6. PubMed ID: 10213639
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Renoprotective effect of triple therapy with low-dose angiotensin receptor blocker, low-dose diuretic and Ca-antagonist in hypertensive type 2 diabetic patients with overt nephropathy].
    Kuriyama S, Tomonari H, Ohtsuka Y, Ohkido I, Hosoya T.
    Nihon Jinzo Gakkai Shi; 2003 May 30; 45(4):367-71. PubMed ID: 12806973
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Randomized controlled crossover study of the effect on proteinuria and blood pressure of adding an angiotensin II receptor antagonist to an angiotensin converting enzyme inhibitor in normotensive patients with chronic renal disease and proteinuria.
    Kincaid-Smith P, Fairley K, Packham D.
    Nephrol Dial Transplant; 2002 Apr 30; 17(4):597-601. PubMed ID: 11917051
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Thiazide diuretics enhance nocturnal blood pressure fall and reduce proteinuria in immunoglobulin A nephropathy treated with angiotensin II modulators.
    Uzu T, Harada T, Namba T, Yamamoto R, Takahara K, Yamauchi A, Kimura G.
    J Hypertens; 2005 Apr 30; 23(4):861-5. PubMed ID: 15775792
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.